Align Technology | ALGN - Ebit

Stock Price
184.59
Daily Change
3.33 1.84%
Monthly
10.10%
Yearly
-3.21%
Q1 Forecast
184.13

Align Technology reported $224.71M in EBIT for its fiscal quarter ending in December of 2025.





Ebit Change Date
3M USD 1.21B 394M Dec/2025
Align Technology USD 224.71M 40.06M Dec/2025
Becton, Dickinson and Co. USD 663M 163M Dec/2025
Bruker USD 76.3M 7.6M Dec/2025
Cardinal Health USD 763M 9M Dec/2025
Charles River Laboratories USD 75.82M 57.98M Dec/2025
Cooper Companies USD 140.4M 35.3M Sep/2025
CVS Health USD 2.11B 836M Dec/2025
Danaher USD 1.5B 348M Dec/2025
Dentsply International USD 512M 401M Sep/2025
Dexcom USD 323M 80.5M Dec/2025
Henry Schein USD 186M 12M Dec/2025
Idexx Laboratories USD 315.6M 39.24M Dec/2025
Insulet USD 146.3M 28.6M Dec/2025
Integra LifeSciences USD 11.76M 521.67M Sep/2025
IQVIA Holdings USD 2.68B 2.1B Dec/2025
Masimo USD 83.7M 19.2M Sep/2025
McKesson USD 1.66B 159M Dec/2025
Mettler Toledo International USD 351.93M 57.73M Dec/2025
Revvity USD 145.83M 47.49M Dec/2025
Solventum Corp USD 1.69B 1.47B Sep/2025
Stryker USD 1.97B 609M Dec/2025
Teleflex USD 112.65M 44.3M Sep/2025
Thermo Fisher Scientific USD 2.3B 226M Dec/2025
Veeva Systems USD 240.85M 14.32M Sep/2025
Waters USD 270.52M 78.4M Dec/2025
Zimmer Biomet Holdings USD 302.9M 35.4M Dec/2025
Zoetis USD 835M 140M Dec/2025